0
Upcoming Allied Market Research
2023
Ileostomy Market

Ileostomy Market: Global Opportunity Analysis and Industry Forecast, 2019-2026 Market

Report Code: A07451
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Ileostomy Market

Request Now !

Ileostomy is the surgical procedure an opening is created using surgical devices in the ileum, which is the lowest part of the small intestine and then aligned such that it gets attached with the abdominal wall. The intestinal part is basically brought through to the abdominal wall for the formation of stoma. The customization can be done for permanent or temporary basis and may help in removal of all or a particular part of the colon. The ileostomy is carried out to assist with the removal of the waste from the body. The surgery is carried out when the part of the rectum or colon is not working. The surgical procedures include total abdominal colectomy, total proctocolectomy, and small bowel resection.

Ileostomy

COVID-19 scenario analysis: 

The global impact of the coronavirus is humongous as the complete lock down alert has been declared by the government organizations worldwide. The only preventive measures that can be carried out involves shut down of every region where gathering could be possible and hence, causing the downfall in the production and manufacturing of every product from every sector. However, the healthcare sector is affected in a positive way for the parameters that are required for the treatment of COVID-19 while other segments such as nutraceutical consumption, surgical procedures are immensely affected in a negative direction. Furthermore, there is a rise in the digital platform as a way to help the doctors and patient connect and hence get access to the prescription online, which is anticipated to boost the market of OTC drugs. Pharmaceutical and biotechnology industries are hence observing a lucrative growth in the forecast period.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The rise in the awareness and concern over the ostomy care brought up by the various non-profit organizations and private players which would help the market grow in the coming years. The key market players are investing more over the R&D to bring up function-rich pouching systems and various accessories for the ileostomy surgeries would boost the industry in the near future. The advancement in the post-ileostomy procedure includes the use of disposable type of ostomy bags and hence helping with cost benefits offered by the disposable bags would flourish the market during forecast period. However, unfavorable reimbursement policies may impede the growth. In addition, the reluctance among the patients for the surgery among the patients may hinder the growth of the industry in the near future.

The global Ileostomy market trends are as follows:

New product launches to flourish the market

The key leaders are focusing on the R&D of the products which are used for the ileostomy would help the Ileostomy market to grow in the coming years. The products are innovated and designed according to the need of the hour. For instance, in March 2017, Flexpoint Sensor Systems, Inc. and 11 Health and Technologies, announced the launch and commercialization of the product ostom-I Alert Sensor. The product has an added advantage of the colostomy care management system and helps in enhancement of the ostomy bag implementations.

The need of the hour is to bring up accessories which are convenient for use and the innovation of the products is initiated to gain maximum shares in the coming years. For instance, Hollister Corporation launched stoma bag with a lubricating deodorant which helps in neutralizing the odor and hence boosts the compatibility of ostomy patients.

Surge in the prevalence of GIT infections 

The rise in the incidences of the diseases which needs surgical assistance include ulcerative colitis, Crohn's disease, constipation, familial adenomatous polyposis and total colonic Hirschsprung’s disease, are anticipated to propel the market in the coming years. Furthermore, the increase in the number of incidences of ovarian cancer or colorectal cancer is also expected to boost the Ileostomy market in the coming years.

The rise in the concern of the individuals for better quality of life would increase the demand for the treatment of the diseases wherein the guts are affected would boost the Ileostomy market in the forecast period. The increase in the awareness for the symptoms of the gut diseases and the treatment or therapeutics of the diseases would help the market flourish.

Key benefits of the report:

  • This study presents the analytical depiction of the global Ileostomy industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Ileostomy market share.
  • The current market is quantitatively analyzed to highlight the global Ileostomy market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Ileostomy market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Ileostomy Market research report:

  • Who are the leading market players active in the Ileostomy market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the Ileostomy market?
  • What are the projections for the future that would help in taking further strategic steps?

Ileostomy Market: Global Opportunity Analysis and Industry Forecast, 2019–2026 Report Highlights

Aspects Details
By Procedure
  • Loop Ileostomy
  • End Ileostomy
By Equipment
  • Belt and Girdles
  • Stoma Bags
  • Adhesive Sprays
  • Stoma Guards
  • Others
By Applications
  • Ulcerative colitis
  • Cancer
  • Crohn’s Disease
  • Diverticulitis
  • Others
By End Users
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (US, Canada)
  • Europe  (Germany, UK, France, rest of Europe)
  • Asia-Pacific  (China, Japan, India, rest of Asia-Pacific)
  • Latin America  (Brazil, Mexico, rest of LATAM)
  • the Middle East 
  • Africa 
Key Market Players Marlen Manufacturing, 3M, B. Braun Melsungen AG, ConvaTec Inc., Coloplast A/S, Salts Healthcare, Pelican Healthcare, Smith and Nephew, Flexicare Medical Ltd.
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ILEOSTOMY MARKET, BY PROCEDURE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Procedure

    • 4.2. Loop Ileostomy

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. End Ileostomy

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: ILEOSTOMY MARKET, BY EQUIPMENT

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Equipment

    • 5.2. Belt And Girdles

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Stoma Bags

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Adhesive Sprays

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Stoma Guards

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Others

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: ILEOSTOMY MARKET, BY APPLICATIONS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Applications

    • 6.2. Ulcerative Colitis

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Cancer

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Crohn’s Disease

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Diverticulitis

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Others

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: ILEOSTOMY MARKET, BY END USERS

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End Users

    • 7.2. Hospitals

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Ambulatory Surgical Centers

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Others

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: ILEOSTOMY MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Procedure

      • 8.2.3. Market Size and Forecast, By Equipment

      • 8.2.4. Market Size and Forecast, By Applications

      • 8.2.5. Market Size and Forecast, By End Users

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Ileostomy Market

        • 8.2.7.1. Market Size and Forecast, By Procedure
        • 8.2.7.2. Market Size and Forecast, By Equipment
        • 8.2.7.3. Market Size and Forecast, By Applications
        • 8.2.7.4. Market Size and Forecast, By End Users
      • 8.2.8. Canada Ileostomy Market

        • 8.2.8.1. Market Size and Forecast, By Procedure
        • 8.2.8.2. Market Size and Forecast, By Equipment
        • 8.2.8.3. Market Size and Forecast, By Applications
        • 8.2.8.4. Market Size and Forecast, By End Users
      • 8.2.9. Mexico Ileostomy Market

        • 8.2.9.1. Market Size and Forecast, By Procedure
        • 8.2.9.2. Market Size and Forecast, By Equipment
        • 8.2.9.3. Market Size and Forecast, By Applications
        • 8.2.9.4. Market Size and Forecast, By End Users
    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Procedure

      • 8.3.3. Market Size and Forecast, By Equipment

      • 8.3.4. Market Size and Forecast, By Applications

      • 8.3.5. Market Size and Forecast, By End Users

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Ileostomy Market

        • 8.3.7.1. Market Size and Forecast, By Procedure
        • 8.3.7.2. Market Size and Forecast, By Equipment
        • 8.3.7.3. Market Size and Forecast, By Applications
        • 8.3.7.4. Market Size and Forecast, By End Users
      • 8.3.8. Germany Ileostomy Market

        • 8.3.8.1. Market Size and Forecast, By Procedure
        • 8.3.8.2. Market Size and Forecast, By Equipment
        • 8.3.8.3. Market Size and Forecast, By Applications
        • 8.3.8.4. Market Size and Forecast, By End Users
      • 8.3.9. Italy Ileostomy Market

        • 8.3.9.1. Market Size and Forecast, By Procedure
        • 8.3.9.2. Market Size and Forecast, By Equipment
        • 8.3.9.3. Market Size and Forecast, By Applications
        • 8.3.9.4. Market Size and Forecast, By End Users
      • 8.3.10. Spain Ileostomy Market

        • 8.3.10.1. Market Size and Forecast, By Procedure
        • 8.3.10.2. Market Size and Forecast, By Equipment
        • 8.3.10.3. Market Size and Forecast, By Applications
        • 8.3.10.4. Market Size and Forecast, By End Users
      • 8.3.11. UK Ileostomy Market

        • 8.3.11.1. Market Size and Forecast, By Procedure
        • 8.3.11.2. Market Size and Forecast, By Equipment
        • 8.3.11.3. Market Size and Forecast, By Applications
        • 8.3.11.4. Market Size and Forecast, By End Users
      • 8.3.12. Russia Ileostomy Market

        • 8.3.12.1. Market Size and Forecast, By Procedure
        • 8.3.12.2. Market Size and Forecast, By Equipment
        • 8.3.12.3. Market Size and Forecast, By Applications
        • 8.3.12.4. Market Size and Forecast, By End Users
      • 8.3.13. Rest Of Europe Ileostomy Market

        • 8.3.13.1. Market Size and Forecast, By Procedure
        • 8.3.13.2. Market Size and Forecast, By Equipment
        • 8.3.13.3. Market Size and Forecast, By Applications
        • 8.3.13.4. Market Size and Forecast, By End Users
    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Procedure

      • 8.4.3. Market Size and Forecast, By Equipment

      • 8.4.4. Market Size and Forecast, By Applications

      • 8.4.5. Market Size and Forecast, By End Users

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Ileostomy Market

        • 8.4.7.1. Market Size and Forecast, By Procedure
        • 8.4.7.2. Market Size and Forecast, By Equipment
        • 8.4.7.3. Market Size and Forecast, By Applications
        • 8.4.7.4. Market Size and Forecast, By End Users
      • 8.4.8. Japan Ileostomy Market

        • 8.4.8.1. Market Size and Forecast, By Procedure
        • 8.4.8.2. Market Size and Forecast, By Equipment
        • 8.4.8.3. Market Size and Forecast, By Applications
        • 8.4.8.4. Market Size and Forecast, By End Users
      • 8.4.9. India Ileostomy Market

        • 8.4.9.1. Market Size and Forecast, By Procedure
        • 8.4.9.2. Market Size and Forecast, By Equipment
        • 8.4.9.3. Market Size and Forecast, By Applications
        • 8.4.9.4. Market Size and Forecast, By End Users
      • 8.4.10. South Korea Ileostomy Market

        • 8.4.10.1. Market Size and Forecast, By Procedure
        • 8.4.10.2. Market Size and Forecast, By Equipment
        • 8.4.10.3. Market Size and Forecast, By Applications
        • 8.4.10.4. Market Size and Forecast, By End Users
      • 8.4.11. Australia Ileostomy Market

        • 8.4.11.1. Market Size and Forecast, By Procedure
        • 8.4.11.2. Market Size and Forecast, By Equipment
        • 8.4.11.3. Market Size and Forecast, By Applications
        • 8.4.11.4. Market Size and Forecast, By End Users
      • 8.4.12. Thailand Ileostomy Market

        • 8.4.12.1. Market Size and Forecast, By Procedure
        • 8.4.12.2. Market Size and Forecast, By Equipment
        • 8.4.12.3. Market Size and Forecast, By Applications
        • 8.4.12.4. Market Size and Forecast, By End Users
      • 8.4.13. Malaysia Ileostomy Market

        • 8.4.13.1. Market Size and Forecast, By Procedure
        • 8.4.13.2. Market Size and Forecast, By Equipment
        • 8.4.13.3. Market Size and Forecast, By Applications
        • 8.4.13.4. Market Size and Forecast, By End Users
      • 8.4.14. Indonesia Ileostomy Market

        • 8.4.14.1. Market Size and Forecast, By Procedure
        • 8.4.14.2. Market Size and Forecast, By Equipment
        • 8.4.14.3. Market Size and Forecast, By Applications
        • 8.4.14.4. Market Size and Forecast, By End Users
      • 8.4.15. Rest of Asia Pacific Ileostomy Market

        • 8.4.15.1. Market Size and Forecast, By Procedure
        • 8.4.15.2. Market Size and Forecast, By Equipment
        • 8.4.15.3. Market Size and Forecast, By Applications
        • 8.4.15.4. Market Size and Forecast, By End Users
    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Procedure

      • 8.5.3. Market Size and Forecast, By Equipment

      • 8.5.4. Market Size and Forecast, By Applications

      • 8.5.5. Market Size and Forecast, By End Users

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Ileostomy Market

        • 8.5.7.1. Market Size and Forecast, By Procedure
        • 8.5.7.2. Market Size and Forecast, By Equipment
        • 8.5.7.3. Market Size and Forecast, By Applications
        • 8.5.7.4. Market Size and Forecast, By End Users
      • 8.5.8. South Africa Ileostomy Market

        • 8.5.8.1. Market Size and Forecast, By Procedure
        • 8.5.8.2. Market Size and Forecast, By Equipment
        • 8.5.8.3. Market Size and Forecast, By Applications
        • 8.5.8.4. Market Size and Forecast, By End Users
      • 8.5.9. Saudi Arabia Ileostomy Market

        • 8.5.9.1. Market Size and Forecast, By Procedure
        • 8.5.9.2. Market Size and Forecast, By Equipment
        • 8.5.9.3. Market Size and Forecast, By Applications
        • 8.5.9.4. Market Size and Forecast, By End Users
      • 8.5.10. UAE Ileostomy Market

        • 8.5.10.1. Market Size and Forecast, By Procedure
        • 8.5.10.2. Market Size and Forecast, By Equipment
        • 8.5.10.3. Market Size and Forecast, By Applications
        • 8.5.10.4. Market Size and Forecast, By End Users
      • 8.5.11. Argentina Ileostomy Market

        • 8.5.11.1. Market Size and Forecast, By Procedure
        • 8.5.11.2. Market Size and Forecast, By Equipment
        • 8.5.11.3. Market Size and Forecast, By Applications
        • 8.5.11.4. Market Size and Forecast, By End Users
      • 8.5.12. Rest of LAMEA Ileostomy Market

        • 8.5.12.1. Market Size and Forecast, By Procedure
        • 8.5.12.2. Market Size and Forecast, By Equipment
        • 8.5.12.3. Market Size and Forecast, By Applications
        • 8.5.12.4. Market Size and Forecast, By End Users
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Salts Healthcare

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Smith And Nephew

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. 3M

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. B. Braun Melsungen AG

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. ConvaTec Inc.

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Coloplast A/S

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Flexicare Medical Ltd.

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Pelican Healthcare

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Marlen Manufacturing

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ILEOSTOMY MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL ILEOSTOMY MARKET FOR LOOP ILEOSTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL ILEOSTOMY MARKET FOR END ILEOSTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ILEOSTOMY MARKET, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL ILEOSTOMY MARKET FOR BELT AND GIRDLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL ILEOSTOMY MARKET FOR STOMA BAGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL ILEOSTOMY MARKET FOR ADHESIVE SPRAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL ILEOSTOMY MARKET FOR STOMA GUARDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL ILEOSTOMY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ILEOSTOMY MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL ILEOSTOMY MARKET FOR ULCERATIVE COLITIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL ILEOSTOMY MARKET FOR CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL ILEOSTOMY MARKET FOR CROHN’S DISEASE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL ILEOSTOMY MARKET FOR DIVERTICULITIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL ILEOSTOMY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL ILEOSTOMY MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL ILEOSTOMY MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL ILEOSTOMY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL ILEOSTOMY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL ILEOSTOMY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA ILEOSTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 26. U.S. ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 27. U.S. ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 28. U.S. ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 29. U.S. ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 30. CANADA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 31. CANADA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 32. CANADA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 33. CANADA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE ILEOSTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 51. ITALY ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 52. ITALY ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 53. ITALY ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 54. ITALY ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 59. UK ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 60. UK ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 61. UK ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 62. UK ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 63. RUSSIA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 64. RUSSIA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 65. RUSSIA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 66. RUSSIA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 67. REST OF EUROPE ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC ILEOSTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 76. CHINA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 77. CHINA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 78. CHINA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 79. CHINA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 80. JAPAN ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 81. JAPAN ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 82. JAPAN ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 84. INDIA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 85. INDIA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 86. INDIA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 87. INDIA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 92. AUSTRALIA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 93. AUSTRALIA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 94. AUSTRALIA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 95. AUSTRALIA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 96. THAILAND ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 97. THAILAND ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 98. THAILAND ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 99. THAILAND ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 100. MALAYSIA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 101. MALAYSIA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 102. MALAYSIA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 103. MALAYSIA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 104. INDONESIA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 105. INDONESIA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 106. INDONESIA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 107. INDONESIA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA ILEOSTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 117. BRAZIL ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 118. BRAZIL ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 121. SOUTH AFRICA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 125. SAUDI ARABIA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 129. UAE ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 130. UAE ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 131. UAE ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 132. UAE ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 133. ARGENTINA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 135. ARGENTINA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 136. ARGENTINA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LAMEA ILEOSTOMY, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA ILEOSTOMY, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LAMEA ILEOSTOMY, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 140. REST OF LAMEA ILEOSTOMY, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 141. SALTS HEALTHCARE: KEY EXECUTIVES
  • TABLE 142. SALTS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 143. SALTS HEALTHCARE: OPERATING SEGMENTS
  • TABLE 144. SALTS HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 145. SALTS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 147. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 148. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 149. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 150. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. 3M: KEY EXECUTIVES
  • TABLE 152. 3M: COMPANY SNAPSHOT
  • TABLE 153. 3M: OPERATING SEGMENTS
  • TABLE 154. 3M: PRODUCT PORTFOLIO
  • TABLE 155. 3M: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 156. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 157. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 158. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 159. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 160. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 161. CONVATEC INC.: KEY EXECUTIVES
  • TABLE 162. CONVATEC INC.: COMPANY SNAPSHOT
  • TABLE 163. CONVATEC INC.: OPERATING SEGMENTS
  • TABLE 164. CONVATEC INC.: PRODUCT PORTFOLIO
  • TABLE 165. CONVATEC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 166. COLOPLAST A/S: KEY EXECUTIVES
  • TABLE 167. COLOPLAST A/S: COMPANY SNAPSHOT
  • TABLE 168. COLOPLAST A/S: OPERATING SEGMENTS
  • TABLE 169. COLOPLAST A/S: PRODUCT PORTFOLIO
  • TABLE 170. COLOPLAST A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 171. FLEXICARE MEDICAL LTD.: KEY EXECUTIVES
  • TABLE 172. FLEXICARE MEDICAL LTD.: COMPANY SNAPSHOT
  • TABLE 173. FLEXICARE MEDICAL LTD.: OPERATING SEGMENTS
  • TABLE 174. FLEXICARE MEDICAL LTD.: PRODUCT PORTFOLIO
  • TABLE 175. FLEXICARE MEDICAL LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 176. PELICAN HEALTHCARE: KEY EXECUTIVES
  • TABLE 177. PELICAN HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 178. PELICAN HEALTHCARE: OPERATING SEGMENTS
  • TABLE 179. PELICAN HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 180. PELICAN HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 181. MARLEN MANUFACTURING: KEY EXECUTIVES
  • TABLE 182. MARLEN MANUFACTURING: COMPANY SNAPSHOT
  • TABLE 183. MARLEN MANUFACTURING: OPERATING SEGMENTS
  • TABLE 184. MARLEN MANUFACTURING: PRODUCT PORTFOLIO
  • TABLE 185. MARLEN MANUFACTURING: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ILEOSTOMY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ILEOSTOMY MARKET
  • FIGURE 3. SEGMENTATION ILEOSTOMY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ILEOSTOMY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALILEOSTOMY MARKET
  • FIGURE 11. ILEOSTOMY MARKET SEGMENTATION, BY BY PROCEDURE
  • FIGURE 12. ILEOSTOMY MARKET FOR LOOP ILEOSTOMY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ILEOSTOMY MARKET FOR END ILEOSTOMY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ILEOSTOMY MARKET SEGMENTATION, BY BY EQUIPMENT
  • FIGURE 15. ILEOSTOMY MARKET FOR BELT AND GIRDLES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. ILEOSTOMY MARKET FOR STOMA BAGS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. ILEOSTOMY MARKET FOR ADHESIVE SPRAYS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. ILEOSTOMY MARKET FOR STOMA GUARDS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. ILEOSTOMY MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. ILEOSTOMY MARKET SEGMENTATION, BY BY APPLICATIONS
  • FIGURE 21. ILEOSTOMY MARKET FOR ULCERATIVE COLITIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. ILEOSTOMY MARKET FOR CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. ILEOSTOMY MARKET FOR CROHN’S DISEASE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. ILEOSTOMY MARKET FOR DIVERTICULITIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. ILEOSTOMY MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. ILEOSTOMY MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 27. ILEOSTOMY MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. ILEOSTOMY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. ILEOSTOMY MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 31. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 32. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 33. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 34. COMPETITIVE DASHBOARD
  • FIGURE 35. COMPETITIVE HEATMAP: ILEOSTOMY MARKET
  • FIGURE 36. Top player positioning, 2022
  • FIGURE 37. SALTS HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. SALTS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. SALTS HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. SMITH AND NEPHEW: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. 3M: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. 3M: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. 3M: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. CONVATEC INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. CONVATEC INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. CONVATEC INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. COLOPLAST A/S: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. COLOPLAST A/S: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. COLOPLAST A/S: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. FLEXICARE MEDICAL LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. FLEXICARE MEDICAL LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. FLEXICARE MEDICAL LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. PELICAN HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. PELICAN HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. PELICAN HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. MARLEN MANUFACTURING: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. MARLEN MANUFACTURING: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. MARLEN MANUFACTURING: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Ileostomy Market

Start reading.
This Report and over 68,094+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers